As the healthcare system adjusts to the transition to value-based care, providers in particular are having a hard time keeping up with all of the changes, said Andrei Gonzales, director of value-based reimbursement initiatives at McKesson Health Solutions.
As the healthcare system adjusts to the transition to value-based care, providers in particular are having a hard time keeping up with all of the changes, said Andrei Gonzales, director of value-based reimbursement initiatives at McKesson Health Solutions.
Transcript (slightly modified)
What remains the biggest hurdle facing the US in the move to value-based care?
I’d say the biggest hurdle is the transition from the current fee-for-service structure, to a value-based reimbursement structure. The study that we did shows that providers are struggling, and they are lagging payers in their progression towards value-based reimbursement.
And you know, providers have a very busy job right now just to take care of their patients, and the transition requires a lot of work in terms of building care coordination capabilities, in terms of building data integration so that all the different stakeholders in the continuum of care really understand what’s happening for their patients in these value-based models and understand where opportunities for improvement are, and to be able to make those changes to really see the improvements that they’re looking for. So that transition is going to be a very heavy lift; it has been and it’s going to continue to be until we reach more of a steady state and gone through this transition phase.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Minimizing Terms for Toxicity Often Used in Multiple Myeloma Trials, Study Says
November 22nd 2023A cohort study of 65 clinical trials in multiple myeloma found that toxic effects are often described with subjective terminology that may not reflect adverse event rates reported in the studies.
Read More